Announce Date | 02/06/2025 |
EPS Normalized Actual | $1.01 (Beat by $0.08) |
EPS GAAP Actual | $1.01 (Beat by $0.08) |
Revenue Actual | $3.439B |
Revenue Surprise | Beat by $3439M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 5.4628 | 4.66 | 5.23929 | 6.11818 | 1 |
Dec 2028 | 6.3 | 4.04 | 6.08359 | 6.58689 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -1.85 | -1.85 | 3.439B | 45.45% | 3439M |
FQ3 2024 (Sep 2024) | 1.05 | 1.05 | 3.449B | -5.02% | 3449M |
FQ2 2024 (Jun 2024) | 1.34 | 1.34 | 3.603B | -25.45% | 3603M |
FQ1 2024 (Mar 2024) | 0.9 | 0.9 | 3.595B | -16.27% | 3595M |
FQ4 2023 (Dec 2023) | 0.66 | 0.66 | 1.876B | -118.98% | 1876M |
FQ3 2023 (Sep 2023) | 0.21 | 0.21 | 3.622B | -12.09% | 3622M |
FQ2 2023 (Jun 2023) | 0.87 | 0.87 | 4.52B | 16.84% | 4520M |
FQ1 2023 (Mar 2023) | 0.93 | 0.93 | 4.18B | 100% | 4180M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.4098 | -- | 1.4098 | 1.4098 | 8 |
FQ3 2027 (Jul 2027) | 1.4003 | -- | 1.4003 | 1.4003 | 5 |
FQ2 2027 (Jun 2027) | 1.5698 | -- | 1.52099 | 1.62823 | 8 |
FQ1 2027 (Mar 2027) | 1.3184 | -- | 1.27741 | 1.36747 | 8 |
FQ4 2026 (Oct 2026) | 1.30263 | -- | 1.24747 | 1.36788 | 7 |
FQ3 2026 (Jul 2026) | 1.3149 | -- | 1.25922 | 1.38076 | 4 |
FQ2 2026 (Jun 2026) | 1.2251 | -- | 1.15382 | 1.29999 | 4 |
FQ1 2026 (Mar 2026) | 1.11607 | -- | 1.05113 | 1.1843 | 4 |
FQ4 2025 (Oct 2025) | 1.17323 | 257.68 | 1.12355 | 1.232 | 7 |
FQ3 2025 (Sep 2025) | 1.11524 | 5.85 | 1.05035 | 1.18342 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 4.35B | -- | 4.35B | 4.35B | 5 |
FQ3 2027 (Jul 2027) | 4.43B | -- | 4.43B | 4.43B | 5 |
FQ2 2027 (Jun 2027) | 4.53B | -- | 4.42B | 4.66B | 4 |
FQ1 2027 (Mar 2027) | 4.32B | -- | 4.22B | 4.45B | 7 |
FQ4 2026 (Oct 2026) | 4.15B | -- | 4.01B | 4.31B | 5 |
FQ3 2026 (Jul 2026) | 4.2B | -- | 4.06B | 4.36B | 5 |
FQ2 2026 (Jun 2026) | 4.19B | -- | 4B | 4.38B | 5 |
FQ1 2026 (Mar 2026) | 3.98B | -- | 3.8B | 4.17B | 5 |
FQ4 2025 (Oct 2025) | 3.91B | 12.05 | 3.78B | 4.06B | 4 |
FQ3 2025 (Sep 2025) | 3.9B | 11.49 | 3.72B | 4.08B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -1.85 | -1.85 | 100% | |
FQ3 2024 (Sep 2024) | 1.05 | 1.05 | 100% | |
FQ2 2024 (Jun 2024) | 1.34 | 1.34 | 100% | |
FQ1 2024 (Mar 2024) | 0.9 | 0.9 | 100% | |
FQ4 2023 (Dec 2023) | 0.66 | 0.66 | 100% | |
FQ3 2023 (Sep 2023) | 0.21 | 0.21 | 100% | |
FQ2 2023 (Jun 2023) | 0.87 | 0.87 | 100% | |
FQ1 2023 (Mar 2023) | 0.93 | 0.93 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $3.44B | $3439M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.45B | $3449M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.6B | $3603M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.6B | $3595M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.88B | $1876M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.62B | $3622M | 100% |
FQ2 2023 (Jun 2023) | $0B | $4.52B | $4520M | 100% |
FQ1 2023 (Mar 2023) | $0B | $4.18B | $4180M | 100% |